Ignite Creation Date:
2025-12-24 @ 9:16 PM
Ignite Modification Date:
2026-01-04 @ 4:09 AM
Study NCT ID:
NCT00989404
Status:
COMPLETED
Last Update Posted:
2017-06-14
First Post:
2009-09-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Crossover Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Repeat Dose Zanamivir/Placebo Via Devices Administered Twice Daily for 5 Days
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-10-12
Start Date Type:
ACTUAL
Primary Completion Date:
2009-12-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12-07
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-24
First Submit QC Date:
None
Study First Post Date:
2009-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-13
Last Update Post Date:
2017-06-14
Last Update Post Date Type:
ACTUAL